Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 974 of 1,261

  1. US 7880007

    Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  2. US 7879909

    Use of Treprostinil to treat neuropathic diabetic foot ulcers

    United Therapeutics Corporation · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  3. US 7880008

    Heterocycles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  4. US 7880010

    Crystalline forms of a dimethylphenyl compound

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  5. US 7879984

    Human antibodies to human CD20 and method of using thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  6. US 7879564

    Use of the receptor GPR86

    Takeda Pharmaceutical Company Limited · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  7. US 7879576

    Marine actinomycete taxon for drug and fermentation product discovery

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  8. US 7879548

    Detection of biomarkers for neuropsychiatric disorders

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  9. US 7879334

    Fusion molecules and treatment of IgE-mediated allergic diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  10. US 7879370

    Composition of which chief ingredient is polysaccharides having an immunoregulatory function

    American Regent, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  11. US 7879324

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  12. US 7875622

    Methods and compositions for treating pulmonary hypertension and related diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  13. US 7875628

    Cyclopamine analogues and methods of use thereof

    Infinity Discovery, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  14. US 7875276

    Urinary tract tissue graft compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  15. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  16. US 7875284

    Methods of manufacturing and modifying taxane coatings for implantable medical devices

    Cook Regentec LLC · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  17. US 7875292

    Orally disintegrable tablets

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  18. US 7875637

    Benzimidazole derivative and use as a II receptor antagonist

    Takeda Pharmaceutical Company Limited · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  19. US 7875711

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  20. US 7875450

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  21. US 7875629

    Quinolinone compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  22. US 7875712

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  23. US 7875598

    Compositions useful for the treatment of microbial infections

    The Regents of the University of California · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  24. US 7875632

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.